Johnson & Johnson (FRA:JNJ)
€ 138.92 -0.18 (-0.13%) Market Cap: 334.68 Bil Enterprise Value: 341.56 Bil PE Ratio: 9.88 PB Ratio: 5.15 GF Score: 83/100

Johnson & Johnson Investor Conference Call on Voluntary Baby Powder Lot Recall Transcript

Oct 18, 2019 / 03:30PM GMT
Release Date Price: €116 (-5.84%)
Operator

Good morning, and welcome to the Johnson & Johnson conference call. (Operator Instructions) This call is being recorded. If anyone has any objections, you may disconnect at this time. (Operator Instructions)

I will now like to turn the call over to Chris DelOrefice, Vice President of Investor Relations for Johnson & Johnson. Thank you. You may begin.

Chris DelOrefice
Johnson & Johnson - VP of IR

Great. Thank you, everyone, for taking the time to connect today. Joining me today is Kathy Wengel, Executive Vice President and Chief Global Supply Chain Officer; Dr. Susan Nicholson, Vice President of Women's Health in our medical safety organization; and Lynne Szczepaniak, Vice President, Regulatory Affairs, Consumer.

As you saw, we did issue a press release earlier today about our voluntary recall of 1 lot of Johnson's Baby Powder. Product quality and safety are important issues for us, and we know that they're important to you as well. While Johnson & Johnson is continuing to investigate the matter in cooperation with the FDA, we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot